Telmisartan in Respiratory Failure Due to COVID-19

Clinical trial NCT04510662 · COMPLETED

Trial details

NCT number: NCT04510662
Sponsor: Abraham Edgar Gracia-Ramos
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Respiratory Insufficiency Telmisartan Respiratory Distress Syndrome, Adult

Start date: 2020-08-12
Primary completion: 2021-05-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.